These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 32038257)

  • 1. Amphetamine Derivatives as Monoamine Oxidase Inhibitors.
    Reyes-Parada M; Iturriaga-Vasquez P; Cassels BK
    Front Pharmacol; 2019; 10():1590. PubMed ID: 32038257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships.
    Scorza MC; Carrau C; Silveira R; Zapata-Torres G; Cassels BK; Reyes-Parada M
    Biochem Pharmacol; 1997 Dec; 54(12):1361-9. PubMed ID: 9393679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological profile of mephedrone analogs and related new psychoactive substances.
    Luethi D; Kolaczynska KE; Docci L; Krähenbühl S; Hoener MC; Liechti ME
    Neuropharmacology; 2018 May; 134(Pt A):4-12. PubMed ID: 28755886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [INTERFERENCE BY D-AMPHETAMINE IN THE ACTION OF SOME MONOAMINE OXIDASE INHIBITORS].
    FERRI S; MAFFEI-FACCIOLI A; ORNESI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1381-4. PubMed ID: 14123621
    [No Abstract]   [Full Text] [Related]  

  • 5. INHIBITION OF MONOAMINE OXIDASE ACTION ON KYNURAMINE BY SUBSTRATE AMINES AND STEREOISOMERIC ALPHA-METHYL AMINES.
    FULLER RW; WALTERS CP
    Biochem Pharmacol; 1965 Feb; 14():159-63. PubMed ID: 14332461
    [No Abstract]   [Full Text] [Related]  

  • 6. Human placental monoamine transporters as targets for amphetamines.
    Ramamoorthy JD; Ramamoorthy S; Leibach FH; Ganapathy V
    Am J Obstet Gynecol; 1995 Dec; 173(6):1782-7. PubMed ID: 8610762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain.
    Steele TD; Nichols DE; Yim GK
    Biochem Pharmacol; 1987 Jul; 36(14):2297-303. PubMed ID: 2886126
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Luethi D; Walter M; Zhou X; Rudin D; Krähenbühl S; Liechti ME
    Front Pharmacol; 2019; 10():438. PubMed ID: 31068823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MONOAMINE OXIDASE INHIBITORS.
    PERKS ER
    Anaesthesia; 1964 Jul; 19():376-86. PubMed ID: 14174638
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacologic profile of amphetamine derivatives at various brain recognition sites: selective effects on serotonergic systems.
    Battaglia G; De Souza EB
    NIDA Res Monogr; 1989; 94():240-58. PubMed ID: 2514364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p-Methoxyamphetamine, a potent reversible inhibitor of type-A monoamine oxidase in vitro and in vivo.
    Green AL; El Hait MA
    J Pharm Pharmacol; 1980 Apr; 32(4):262-6. PubMed ID: 6103055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the mechanism of action of amphetamines.
    Fleckenstein AE; Volz TJ; Riddle EL; Gibb JW; Hanson GR
    Annu Rev Pharmacol Toxicol; 2007; 47():681-98. PubMed ID: 17209801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SELF-STIMULATION OF THE BRAIN AND THE CENTRAL STIMULANT ACTION OF AMPHETAMINE.
    STEIN L
    Fed Proc; 1964; 23():836-50. PubMed ID: 14195468
    [No Abstract]   [Full Text] [Related]  

  • 15. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C; Reither H; Hornykiewicz O
    Eur J Pharmacol; 2015 May; 755():119-26. PubMed ID: 25771452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Selectivity and Partial Efficacy at the Monoamine Transporters: A Unified Model of Allosteric Modulation and Amphetamine-Induced Substrate Release.
    Hasenhuetl PS; Bhat S; Freissmuth M; Sandtner W
    Mol Pharmacol; 2019 Mar; 95(3):303-312. PubMed ID: 30567955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MECHANISM OF ACTION OF MONOAMINE OXIDASE INHIBITORS IN ENHANCING AMPHETAMINE TOXICITY.
    BRITTAIN RT; JACK D; SPENCER PS
    J Pharm Pharmacol; 1964 Aug; 16():565-7. PubMed ID: 14223999
    [No Abstract]   [Full Text] [Related]  

  • 18. EFFECTS OF RESERPINE PRE-TREATMENT ON THE PROTECTIVE ACTION OF AMPHETAMINE AND PHENOXYPROPAZINE IN THE PHENYLBENZOQUINONE-INDUCED WRITHING SYNDROME IN MICE.
    DAVIS RA; HORLINGTON M
    Nature; 1964 Jan; 201():306-7. PubMed ID: 14110466
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoamine oxidase inhibitory properties of optical isomers and N-substituted derivatives of 4-methylthioamphetamine.
    Hurtado-Guzmán C; Fierro A; Iturriaga-Vásquez P; Sepúlveda-Boza S; Cassels BK; Reyes-Parada M
    J Enzyme Inhib Med Chem; 2003 Aug; 18(4):339-47. PubMed ID: 14567549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naphthylisopropylamine and N-benzylamphetamine derivatives as monoamine oxidase inhibitors.
    Vilches-Herrera M; Miranda-Sepúlveda J; Rebolledo-Fuentes M; Fierro A; Lühr S; Iturriaga-Vasquez P; Cassels BK; Reyes-Parada M
    Bioorg Med Chem; 2009 Mar; 17(6):2452-60. PubMed ID: 19243954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.